Package 61442-114-01

{"route": ["ORAL"], "spl_id": "209d3e94-5d8e-8799-e063-6394a90ab9d1", "openfda": {"nui": ["N0000020060", "N0000180187", "N0000180188", "N0000175468", "N0000175459"], "unii": ["X4HES1O11F"], "rxcui": ["197310"], "spl_set_id": ["37499620-6a17-40f1-b0db-dd79320ea21d"], "pharm_class_epc": ["Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]"], "pharm_class_moa": ["DNA Polymerase Inhibitors [MoA]"], "manufacturer_name": ["Carlsbad Technology, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "12 BOTTLE, PLASTIC in 1 BOX (61442-114-01)  / 100 CAPSULE in 1 BOTTLE, PLASTIC", "package_ndc": "61442-114-01", "marketing_start_date": "20170817"}, {"sample": false, "description": "12 BOTTLE, PLASTIC in 1 BOX (61442-114-05)  / 500 CAPSULE in 1 BOTTLE, PLASTIC", "package_ndc": "61442-114-05", "marketing_start_date": "20170817"}], "brand_name": "Acyclovir", "product_id": "61442-114_209d3e94-5d8e-8799-e063-6394a90ab9d1", "dosage_form": "CAPSULE", "pharm_class": ["DNA Polymerase Inhibitors [MoA]", "Herpes Simplex Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpes Zoster Virus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC]", "Nucleoside Analog [EXT]"], "product_ndc": "61442-114", "generic_name": "Acyclovir", "labeler_name": "Carlsbad Technology, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Acyclovir", "active_ingredients": [{"name": "ACYCLOVIR", "strength": "200 mg/1"}], "application_number": "ANDA206261", "marketing_category": "ANDA", "marketing_start_date": "20170817", "listing_expiration_date": "20261231"}